Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Aberrant splicing of U12-type introns is the hallmark of ZRSR2 mutant myelodysplastic syndrome
Vikas Madan, Deepika Kanojia, Jia Li, et al.
Nature Communications (2015) Vol. 6, Iss. 1
Open Access | Times Cited: 220

Showing 1-25 of 220 citing articles:

RNA splicing factors as oncoproteins and tumour suppressors
Heidi Dvinge, Eun Hee Kim, Omar Abdel‐Wahab, et al.
Nature reviews. Cancer (2016) Vol. 16, Iss. 7, pp. 413-430
Open Access | Times Cited: 603
Roles and mechanisms of alternative splicing in cancer — implications for care
Sophie Bonnal, Irene López‐Oreja, Juan Valcárcel
Nature Reviews Clinical Oncology (2020) Vol. 17, Iss. 8, pp. 457-474
Closed Access | Times Cited: 565
The Functional Impact of Alternative Splicing in Cancer
Héctor Climente-González, Eduard Porta‐Pardo, Adam Godzik, et al.
Cell Reports (2017) Vol. 20, Iss. 9, pp. 2215-2226
Open Access | Times Cited: 508
Somatic Mutational Landscape of Splicing Factor Genes and Their Functional Consequences across 33 Cancer Types
Michael Seiler, Shouyong Peng, Anant A. Agrawal, et al.
Cell Reports (2018) Vol. 23, Iss. 1, pp. 282-296.e4
Open Access | Times Cited: 398
Alternative‐splicing defects in cancer: Splicing regulators and their downstream targets, guiding the way to novel cancer therapeutics
Laura M. Urbanski, Nathan K. Leclair, Olga Anczuków
Wiley Interdisciplinary Reviews - RNA (2018) Vol. 9, Iss. 4
Open Access | Times Cited: 327
Alternative splicing and cancer: a systematic review
Yuanjiao Zhang, Jinjun Qian, Chunyan Gu, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 304
Lessons from non-canonical splicing
Christopher R. Sibley, Lorea Blázquez, Jernej Ule
Nature Reviews Genetics (2016) Vol. 17, Iss. 7, pp. 407-421
Open Access | Times Cited: 284
Aberrant RNA Splicing in Cancer
Luisa F. Escobar‐Hoyos, Katherine Knorr, Omar Abdel‐Wahab
Annual Review of Cancer Biology (2018) Vol. 3, Iss. 1, pp. 167-185
Open Access | Times Cited: 284
The genomic landscape of juvenile myelomonocytic leukemia
Elliot Stieglitz, Amaro Taylor‐Weiner, Tiffany Chang, et al.
Nature Genetics (2015) Vol. 47, Iss. 11, pp. 1326-1333
Open Access | Times Cited: 263
Splicing-factor alterations in cancers
Olga Anczuków, Adrian R. Krainer
RNA (2016) Vol. 22, Iss. 9, pp. 1285-1301
Open Access | Times Cited: 256
RNA splicing dysregulation and the hallmarks of cancer
Robert K. Bradley, Olga Anczuków
Nature reviews. Cancer (2023) Vol. 23, Iss. 3, pp. 135-155
Open Access | Times Cited: 249
Impact of spliceosome mutations on RNA splicing in myelodysplasia: dysregulated genes/pathways and clinical associations
Andrea Pellagatti, Richard N. Armstrong, Violetta Steeples, et al.
Blood (2018) Vol. 132, Iss. 12, pp. 1225-1240
Open Access | Times Cited: 210
Defective control of pre–messenger RNA splicing in human disease
Benoı̂t Chabot, Lulzim Shkreta
The Journal of Cell Biology (2016) Vol. 212, Iss. 1, pp. 13-27
Open Access | Times Cited: 203
A dynamic intron retention program enriched in RNA processing genes regulates gene expression during terminal erythropoiesis
Harold Pimentel, Marilyn Parra, Sherry L. Gee, et al.
Nucleic Acids Research (2015) Vol. 44, Iss. 2, pp. 838-851
Open Access | Times Cited: 184
RNA Splicing and Cancer
Eric Wang, Iannis Aifantis
Trends in cancer (2020) Vol. 6, Iss. 8, pp. 631-644
Closed Access | Times Cited: 184
The changing paradigm of intron retention: regulation, ramifications and recipes
Geoffray Monteuuis, Justin Wong, Charles G. Bailey, et al.
Nucleic Acids Research (2019)
Open Access | Times Cited: 147
Dysregulation and therapeutic targeting of RNA splicing in cancer
Robert Stanley, Omar Abdel‐Wahab
Nature Cancer (2022) Vol. 3, Iss. 5, pp. 536-546
Open Access | Times Cited: 104
The pathogenicity of splicing defects: mechanistic insights into pre‐ mRNA processing inform novel therapeutic approaches
Élisabeth Daguenet, Gwendal Dujardin, Juan Valcárcel
EMBO Reports (2015) Vol. 16, Iss. 12, pp. 1640-1655
Open Access | Times Cited: 133
Comprehensive mutational analysis of primary and relapse acute promyelocytic leukemia
Vikas Madan, Pavithra Shyamsunder, Lin Han, et al.
Leukemia (2016) Vol. 30, Iss. 8, pp. 1672-1681
Open Access | Times Cited: 129
Altered RNA Processing in Cancer Pathogenesis and Therapy
Esther A. Obeng, Connor Stewart, Omar Abdel‐Wahab
Cancer Discovery (2019) Vol. 9, Iss. 11, pp. 1493-1510
Open Access | Times Cited: 126
Splicing factor gene mutations in hematologic malignancies
Borja Sáez, Matthew J. Walter, Timothy A. Graubert
Blood (2016) Vol. 129, Iss. 10, pp. 1260-1269
Open Access | Times Cited: 120
Spliceosomal gene mutations in myelodysplasia: molecular links to clonal abnormalities of hematopoiesis
Daichi Inoue, Robert K. Bradley, Omar Abdel‐Wahab
Genes & Development (2016) Vol. 30, Iss. 9, pp. 989-1001
Open Access | Times Cited: 105
Minor spliceosome and disease
Bhupendra Verma, Maureen V. Akinyi, Antto J. Norppa, et al.
Seminars in Cell and Developmental Biology (2017) Vol. 79, pp. 103-112
Open Access | Times Cited: 94
PRMT5 Modulates Splicing for Genome Integrity and Preserves Proteostasis of Hematopoietic Stem Cells
Darren Qiancheng Tan, Ying Li, Chong Yang, et al.
Cell Reports (2019) Vol. 26, Iss. 9, pp. 2316-2328.e6
Open Access | Times Cited: 92
Regulation of alternative mRNA splicing: old players and new perspectives
Heidi Dvinge
FEBS Letters (2018) Vol. 592, Iss. 17, pp. 2987-3006
Open Access | Times Cited: 86
Page 1 - Next Page

Scroll to top